Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 2
1998 4
1999 3
2000 1
2001 2
2003 3
2004 1
2005 1
2006 3
2007 2
2008 4
2009 1
2010 4
2011 3
2012 1
2013 2
2014 4
2015 4
2016 4
2017 3
2018 6
2019 8
2020 3
2021 4
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

69 results
Results by year
Filters applied: . Clear all
Page 1
TRAILblazing Strategies for Cancer Treatment.
Kretz AL, Trauzold A, Hillenbrand A, Knippschild U, Henne-Bruns D, von Karstedt S, Lemke J. Kretz AL, et al. Among authors: trauzold a. Cancers (Basel). 2019 Mar 30;11(4):456. doi: 10.3390/cancers11040456. Cancers (Basel). 2019. PMID: 30935038 Free PMC article. Review.
TRAIL-receptor 2-a novel negative regulator of p53.
Willms A, Schupp H, Poelker M, Adawy A, Debus JF, Hartwig T, Krichel T, Fritsch J, Singh S, Walczak H, von Karstedt S, Schäfer H, Trauzold A. Willms A, et al. Among authors: trauzold a. Cell Death Dis. 2021 Jul 31;12(8):757. doi: 10.1038/s41419-021-04048-1. Cell Death Dis. 2021. PMID: 34333527 Free PMC article.
Cytoplasmic TRAIL-R1 is a positive prognostic marker in PDAC.
Gundlach JP, Hauser C, Schlegel FM, Böger C, Röder C, Röcken C, Becker T, Egberts JH, Kalthoff H, Trauzold A. Gundlach JP, et al. Among authors: trauzold a. BMC Cancer. 2018 Jul 31;18(1):777. doi: 10.1186/s12885-018-4688-8. BMC Cancer. 2018. PMID: 30064384 Free PMC article.
Engineering of CD19 Antibodies: A CD19-TRAIL Fusion Construct Specifically Induces Apoptosis in B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Cells In Vivo.
Winterberg D, Lenk L, Oßwald M, Vogiatzi F, Gehlert CL, Frielitz FS, Klausz K, Rösner T, Valerius T, Trauzold A, Peipp M, Kellner C, Schewe DM. Winterberg D, et al. Among authors: trauzold a. J Clin Med. 2021 Jun 15;10(12):2634. doi: 10.3390/jcm10122634. J Clin Med. 2021. PMID: 34203833 Free PMC article.
TRAIL-Receptor 4 Modulates γδ T Cell-Cytotoxicity Toward Cancer Cells.
Tawfik D, Groth C, Gundlach JP, Peipp M, Kabelitz D, Becker T, Oberg HH, Trauzold A, Wesch D. Tawfik D, et al. Among authors: trauzold a. Front Immunol. 2019 Aug 28;10:2044. doi: 10.3389/fimmu.2019.02044. eCollection 2019. Front Immunol. 2019. PMID: 31555275 Free PMC article.
69 results